In addition, we confirmed that Icaritin showed similar effect in proliferation-inhibition on CD34+ cells derived from CML-BC patients(Fig 1B-d). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.